Compare GSK plc (GSK) vs iShares Bitcoin Trust (IBIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs iShares Bitcoin Trust — how do they compare? GSK plc trades at $50.26 (market cap $102.60B), while iShares Bitcoin Trust trades at $36.14. The key difference: GSK plc pays a 3.57% dividend while iShares Bitcoin Trust pays none, and GSK plc is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.
| GSK | IBIT | |
|---|---|---|
Market Cap | $102.60B | — |
Sector | Health | Crypto-linked |
52-Week High | $61.18 | $71.29 |
52-Week Low | $38.96 | $33.29 |
Enterprise Value | $123.04B | — |
Dividend Yield | 3.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
IBIT trades at $35.89, down 0.94% with bearish technical signals from moving averages. The stock faces selling pressure but shows neutral oscillator readings. Recent news highlights institutional interest with Alpha Zero LLC increasing its position by 43.8% in Q1 2026 (SEC filing, 2026-07-21). Bitcoin ETF flows show selective demand, with IBIT leading recent inflows after seven straight days of buying (ETF Trends, 2026-07-23).
The outlook remains cautious due to technical bearishness and Bitcoin's 44% decline from 2025 peaks. Long-term potential exists from institutional adoption, but investors face volatility risks. Analyst sentiment is mixed, with some recommending accumulation for long-term holders while technical indicators suggest near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About iShares Bitcoin Trust
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →
